These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 29150341)

  • 21. Genetic etiology of isolated low HDL syndrome: incidence and heterogeneity of efflux defects.
    Kiss RS; Kavaslar N; Okuhira K; Freeman MW; Walter S; Milne RW; McPherson R; Marcel YL
    Arterioscler Thromb Vasc Biol; 2007 May; 27(5):1139-45. PubMed ID: 17303779
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlation Between ABCA1 Gene Polymorphism and aopA-I and HDL-C in Abdominal Aortic Aneurysm.
    Zhao L; Jin H; Yang B; Zhang S; Han S; Yin F; Feng Y
    Med Sci Monit; 2016 Jan; 22():172-6. PubMed ID: 26774504
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The association between impairment of HDL cholesterol efflux capacity and atrial remodeling in atrial fibrillation.
    Minami-Takano A; Iwata H; Miyosawa K; Shiozawa T; Hayashi H; Funamizu T; Ishii K; Nozaki Y; Tabuchi H; Sekita G; Shimada K; Sumiyoshi M; Nakazato Y; Daida H; Minamino T
    Sci Rep; 2021 Feb; 11(1):3547. PubMed ID: 33574408
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Niacin Therapy Increases High-Density Lipoprotein Particles and Total Cholesterol Efflux Capacity But Not ABCA1-Specific Cholesterol Efflux in Statin-Treated Subjects.
    Ronsein GE; Hutchins PM; Isquith D; Vaisar T; Zhao XQ; Heinecke JW
    Arterioscler Thromb Vasc Biol; 2016 Feb; 36(2):404-11. PubMed ID: 26681752
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of the cholesteryl ester transfer protein inhibitor, TA-8995, on cholesterol efflux capacity and high-density lipoprotein particle subclasses.
    van Capelleveen JC; Kastelein JJ; Zwinderman AH; van Deventer SJ; Collins HL; Adelman SJ; Round P; Ford J; Rader DJ; Hovingh GK
    J Clin Lipidol; 2016; 10(5):1137-1144.e3. PubMed ID: 27678430
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasminogen promotes cholesterol efflux by the ABCA1 pathway.
    Pamir N; Hutchins PM; Ronsein GE; Wei H; Tang C; Das R; Vaisar T; Plow E; Schuster V; Koschinsky ML; Reardon CA; Weinberg R; Dichek DA; Marcovina S; Getz GS; Heinecke JW
    JCI Insight; 2017 Aug; 2(15):. PubMed ID: 28768900
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Myocardial infarction in a 36-year-old man with combined ABCA1 and APOA-1 deficiency.
    van Capelleveen JC; Kootte RS; Hovingh GK; Bochem AE
    J Clin Lipidol; 2015; 9(3):396-9. PubMed ID: 26073400
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interleukin-32 upregulates the expression of ABCA1 and ABCG1 resulting in reduced intracellular lipid concentrations in primary human hepatocytes.
    Damen MSMA; Dos Santos JC; Hermsen R; Adam van der Vliet J; Netea MG; Riksen NP; Dinarello CA; Joosten LAB; Heinhuis B
    Atherosclerosis; 2018 Apr; 271():193-202. PubMed ID: 29524862
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pitavastatin: novel effects on lipid parameters.
    Chapman MJ
    Atheroscler Suppl; 2011 Nov; 12(3):277-84. PubMed ID: 22152282
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The ATP binding cassette transporter A1 (ABCA1) modulates the development of aortic atherosclerosis in C57BL/6 and apoE-knockout mice.
    Joyce CW; Amar MJ; Lambert G; Vaisman BL; Paigen B; Najib-Fruchart J; Hoyt RF; Neufeld ED; Remaley AT; Fredrickson DS; Brewer HB; Santamarina-Fojo S
    Proc Natl Acad Sci U S A; 2002 Jan; 99(1):407-12. PubMed ID: 11752403
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HDL particle size is a critical determinant of ABCA1-mediated macrophage cellular cholesterol export.
    Du XM; Kim MJ; Hou L; Le Goff W; Chapman MJ; Van Eck M; Curtiss LK; Burnett JR; Cartland SP; Quinn CM; Kockx M; Kontush A; Rye KA; Kritharides L; Jessup W
    Circ Res; 2015 Mar; 116(7):1133-42. PubMed ID: 25589556
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatocyte-specific ABCA1 transfer increases HDL cholesterol but impairs HDL function and accelerates atherosclerosis.
    Feng Y; Lievens J; Jacobs F; Hoekstra M; Van Craeyveld E; Gordts SC; Snoeys J; De Geest B
    Cardiovasc Res; 2010 Nov; 88(2):376-85. PubMed ID: 20562425
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cholesterol Efflux Capacity and Pre-Beta-1 HDL Concentrations Are Increased in Dyslipidemic Patients Treated With Evacetrapib.
    Nicholls SJ; Ruotolo G; Brewer HB; Kane JP; Wang MD; Krueger KA; Adelman SJ; Nissen SE; Rader DJ
    J Am Coll Cardiol; 2015 Nov; 66(20):2201-2210. PubMed ID: 26564598
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic variants in ABCA1 promoter affect transcription activity and plasma HDL level in pigs.
    Dang XY; Chu WW; Shi HC; Yu SG; Han HY; Gu SH; Chen J
    Gene; 2015 Jan; 555(2):414-20. PubMed ID: 25445391
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic association with low concentrations of high density lipoprotein-cholesterol in a pediatric population of the Middle East and North Africa: the CASPIAN-III study.
    Kelishadi R; Haghjooy Javanmard S; Tajadini MH; Mansourian M; Motlagh ME; Ardalan G; Ban M
    Atherosclerosis; 2014 Nov; 237(1):273-8. PubMed ID: 25286446
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel small molecule liver X receptor transcriptional regulator, nagilactone B, suppresses atherosclerosis in apoE-deficient mice.
    Gui Y; Yao S; Yan H; Hu L; Yu C; Gao F; Xi C; Li H; Ye Y; Wang Y
    Cardiovasc Res; 2016 Oct; 112(1):502-14. PubMed ID: 27460841
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of four novel genes contributing to familial elevated plasma HDL cholesterol in humans.
    Singaraja RR; Tietjen I; Hovingh GK; Franchini PL; Radomski C; Wong K; vanHeek M; Stylianou IM; Lin L; Wang L; Mitnaul L; Hubbard B; Winther M; Mattice M; Legendre A; Sherrington R; Kastelein JJ; Akinsanya K; Plump A; Hayden MR
    J Lipid Res; 2014 Aug; 55(8):1693-701. PubMed ID: 24891332
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functional characterization of missense variants affecting the extracellular domains of ABCA1 using a fluorescence-based assay.
    Teigen M; Ølnes ÅS; Bjune K; Leren TP; Bogsrud MP; Strøm TB
    J Lipid Res; 2024 Jan; 65(1):100482. PubMed ID: 38052254
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel rare mutations and promoter haplotypes in ABCA1 contribute to low-HDL-C levels.
    Slatter TL; Jones GT; Williams MJ; van Rij AM; McCormick SP
    Clin Genet; 2008 Feb; 73(2):179-84. PubMed ID: 18199144
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tangier disease caused by compound heterozygosity for ABCA1 mutations R282X and Y1532C.
    Cameron J; Ranheim T; Halvorsen B; Kulseth MA; Leren TP; Berge KE
    Atherosclerosis; 2010 Mar; 209(1):163-6. PubMed ID: 19765707
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.